Parking Management Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

According to a new market research report published by Credence Research, “Parking Management Market (by Offering (Hardware, Software), by Parking Site (On-street Parking & Off-street Parking), by Solution (Parking Access Control & Revenue Generation, Parking Guidance, Parking Security & Surveillance, Parking Reservation Management, and Others), by End-use (Government and Municipality Facilities, Commercial Establishments, Corporate Establishments, Airports and Transport Facilities, Education Facilities, and Others (Residential, Sports, etc.)), by Geography (North America, Europe, Asia Pacific, and Rest of the World)) – Growth, Future Prospects, and Competitive Landscape, 2018 -2026”, the global parking management market is expected to expand at a CAGR of 9.5% during the forecast from 2018 to 2026 .

The complete report is available at https://www.credenceresearch.com/report/parking-management-market

Market Insights

Parking management is crucial to efficiently manage issues of traffic congestion. With rise in the number of on-road vehicles, traffic congestion is increasing at an alarming rate worldwide. According to a recently published research study, around 20% of traffic congestion in developed economies and 40% of congestion in developing economies is a result of drivers struggling to find vacant parking space. This, in turn has augmented the need for intelligent and efficient parking management. Flexible park-assist solutions such as parking guidance, access control, revenue generation, parking reservation, and parking surveillance among others ensures efficient parking management by enabling convenient payment, parking, & exit for drivers, improving vehicle carrying capacity of the parking garage, and also simplifying administrative operations of the parking site owners. Growing adoption of such park-assist solutions, especially at multi-space facilities such as corporate establishments, government & municipal facilities, airports, and commercial complexes, among others is expected to boost the market growth during the forecast period from 2018 to 2026.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59486

The growth and opportunities in the global parking management solutions market coincides with the rise in the number of vehicle ownership. In addition, the ongoing initiatives to promote smart city projects is expected to further magnify demand for intelligent automated parking management solutions worldwide. For instance, Automatic Number Plate Recognition (ANPR) technology has garnered tremendous popularity in the parking management segment over the last few years and is deemed to experience even better adoption, thereby not only augmenting the overall parking management value chain, but also offering investment opportunities for every participant across the ecosystem. Some of the leading players profiled in the study include Streetline, Inc., Parking Technology Services, Amano McGann, Smart Parking Limited, Parkmobile LLC, Swarco AG, SpotHero, ParkWhiz, Nedap N.V., Skidata AG, ParkingPanda, Urbiotica, ParkMe, Inc., The Kapsch Group, SAP SE, and Siemens AG among others.

By Offerings Segment

  • Hardware
  • Software

By Parking Site Segment

  • Off-street Parking
  • On-street Parking

By Solution Segment

  • Parking Access and Revenue Control
  • Parking Guidance
  • Parking Security and Surveillance
  • Parking Reservation Management
  • Others (Parking Analytics, etc.)

By End-use Vertical Segment

  • Government and Municipality Facilities
  • Commercial Establishments
  • Corporate Establishments
  • Airports and Transport Facilities
  • Education Facilities
  • Others (Residential, Sports, etc.)

By Geography

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59486

Wireless Projectors Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

According to a new market research report published by Credence Research “Wireless Projectors Market (by Connectivity: Bluetooth, Wi-Fi and Bluetooth & Wi-Fi; by Resolution: Low Definition and High Definition; by Application: Commercial, Education and Residential) – Growth, Future Prospects, and Competitive Landscape, 2018-2026”, the wireless projectors market estimated to grow with a CAGR of 10.3% during the forecast period from 2018 to 2026.

The complete report is available at https://www.credenceresearch.com/report/wireless-projectors-market

Market Insights

Visual projectors have a significant role in every corporate office and educational institutes. These projectors are connected with devices such as PCs, laptops, tablets or smartphones with the help of connector or HDMI cable. However, this can sometimes create nuisance in connectivity and limits the portability of the projectors. In order to tackle such issues, a new breed of wireless projectors with wireless connectivity was introduced. These projectors are rapidly taking over conventional projectors owing to their wireless connectivity and freedom of mobility they offer. Consequently, wireless projectors market estimated to register significant market growth throughout the forecast period from 2018 to 2026.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59485

The growth of wireless projectors depends considerably on growth of corporate as well as education sectors. The two are the biggest applications for wireless projectors and projected to claim majority of market share of the market. Wireless projectors for residential application are generally restricted for entertainment purpose and therefore, residential application trails corporate and education application in terms of market value. Other in-depth analysis with respect to connectivity and resolution is covered in the published report along with detailed regional analysis.

Competitive Insights:

The research analysis covers exhaustive analysis of leading wireless projector manufacturers including AsusTek Computer Inc., Acer Inc., BenQ Corporation, Dell, Seiko Epson Corporation, Casio Computer Co., Ltd., Hitachi, Ltd., LG Electronics Inc., Panasonic Corporation, and Koninklijke Philips N.V. Big names characterizing the market invited stiff competition among the mentioned players and other local players. Consequently, the profit sharing of each company expected to be hit by the competition. The companies are incorporating new business strategies such as technological development and expansion of distribution network in order to maintain their market share. Several other strategies along with the company profiles of aforementioned companies are discussed in detail in the complete report.

Key Analysis Covered:

  • Consistent development in connectivity channels, lenses & lamps and its effects on the development of wireless projectors market
  • Most prominent applications and their growth supplementing the growth of wireless projectors market
  • Different segments of wireless projector and their standing in terms of market value
  • Growth of education sector and corporate sector stimulating the growth of wirelessly connecting projectors
  • The role played by wireless projectors in smart home and home entertainment systems
  • Highlighting the factors boosting the demand for high definition wireless projectors
  • Significance of developing region such as Asia Pacific, Middle East & Africa and Latin America in overall wireless projectors market

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59485

EEG Equipment Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global EEG Equipment Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global EEG equipment market is set to reach from US$ 760.1 Mn in 2017 to US$ 1,457.3 Mn by 2026 expanding at a CAGR of 7.5% from 2018 to 2026.

Browse the full report EEG Equipment Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/eeg-equipment-market

Market Insights

Electroencephalography has made it possible for researchers to study and understand the complexity of brain activity, processes and structure. EEG has tremendous temporal resolution ranging in milliseconds. The advantageous features associated with EEG techniques are is its relevant tolerability to patients movement in comparison to other neuroimaging techniques where slight physical movement result in erroneous interpretations. It is a silent procedure which helps to understand the responses to auditory stimuli. Researchers are working diligently for the development of wireless EEG by using headsets rather than electrodes.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59484

32-channel EEG devices are leading the product segment for EEG equipment market. Higher adoption by healthcare professionals and latest technical modification have led to the increased popularity for 32-channel EEG devices. Multichannel EEG devices will be the fastest growing market owing to inherent features associated with it such as ability to create histograms and spectrum reviews to generate quantitative analysis for cerebral activity.

Standalone devices are currently reigning the type segment for EEG equipment market. Rampant growth in mental hospitals and diagnostic centers boost the standalone devices market growth. Effective monitoring and easy device management are few attributes that support the standalone devices market growth. Portable devices will be the new trendsetter during the forecast period from 2018 to 2026 on account of increasing demand from rehabilitation centers. Excellent ergonomic designs and low cost propel the portable devices market growth.

North America is currently dominating the geographical segment for EEG equipment market. The major parameters responsible for the growth of EEG equipment in North America are increasing number of people suffering with seizures and Epilepsy. Center for Disease Control and Prevention has reported that in 2015, approximately 1.2% of the US population had been diagnosed with active epilepsy. Rapidly increasing clinics and diagnostic centers drive the market growth of EEG equipment in North America. World Health Organization (WHO) have quoted the prevalence of active epilepsy in Europe to be 4 to 10 per thousand people. Asia Pacific serves as a potential market for the growth of EEG devices on account of rising prevalence of patients suffering with psychological disorders and government funding to develop mental healthcare centers.

The medical device manufacturers actively engaged in the production of EEG equipment market are Cadwell Laboratories, Inc., Electrical Geodesics, Inc., Compumedics, Ltd., G.Tec Medical Engineering GmbH, Koninklijke Philips N.V., Medtronic, Plc., Natus Medical, Inc., NeuroWave Systems, Inc., Nihon Kohden, Inc. and Noraxon U.S.A., Inc.

Key Market Movements:

  • Rising prevalence of neurological disorders
  • Technological advancement in the devices employed for the detection and measurement of cerebral activity
  • Rapid growth in hospitals, diagnostic centers and rehabilitations centers to provide a positive impetus towards EEG equipment market growth

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59484

Retinol (Vitamin A) Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Retinol (Vitamin A) Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global retinol (vitamin A) market is set to expand at a CAGR of 4.8% from 2018 to 2026.

Browse the full report Retinol (Vitamin A) Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/retinol-vitamin-a-market

Market Insights

Retinol (vitamin A) is synthesized by the breakdown of beta-carotene. Commercial production of retinoid typically require the reduction of a pentadiene derivative followed by subsequent hydrolysis of the resulting isomer to extract pure retinol. It is usually stored in the form of ester derivatives such as retinyl palmitate and retinyl acetate due to enhanced oxidation of retinol at room temperature. The market is driven by key factors such as developing healthcare sector, higher disposable income and solid distribution network.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59483

Natural sources such as sweet potato, carrots, eggs and other dairy products provide natural retinoid in daily dietary intake. The quantity retained by the human body is minuscule which is related to the increasing demand for synthetic retinol. Synthetic retinol is the leading and fastest growing market in the type segment on account of the enhanced pharmacodynamic and pharmacokinetic parameters possessed by synthetic retinol.

In the current scenario cosmetic products are ruling the application segment for retinol (vitamin A) market. Reduced serum level of retinol in patients suffering with atopic dermatitis and acne vulgaris increases the popularity of retinol. It works by unclogging the skin pores and enhance the penetration of drug molecules in gel and cream formulation. Fortified food is gathering tremendous attraction on account of the flourishing food and dietary supplement industry.

North America is dominating the geographical segment for retinol (vitamin A) market. According to the Center for Disease Control and Prevention, 3.3 million American citizens are suffering with eye disorders. Rising public health awareness and flourishing dairy industry drive the retinol (vitamin A) market in North America. Rising prevalence of skin disorders such as atopic dermatitis and acne vulgaris propel the retinol (vitamin A) market in Europe. Presence of major players such as Bausch & Lomb Incorporated, DSM and Sigma-Aldrich etc. cater to the local requirement of retinol (vitamin A) in Europe. Asia Pacific serves as a potential market opportunity on account of increasing number of children suffering with retinol (vitamin A) deficiency. Proactive role played by government healthcare agencies by providing food fortification and supplementation to the targeted vitamin A deficient population.

The biotechnology companies manufacturing retinol (vitamin A) are Adisseo, BASF SE, Bausch & Lomb Incorporated, CooperVision, Ion Labs, Inc., DSM, Riken Vitamin Co., Ltd., Seidler Chemical Co, Inc., Sigma-Aldrich and Zhejiang NHU Co., Ltd.

Key Market Movements:

  • Rising prevalence of skin and eyesight disorders throughout the globe
  • Increasing demand for food fortification and dietary supplementation process to fight vitamin A deficiency
  • Easy production, excellent pharmacodynamic & pharmacokinetic profile increases the demand for synthetic retinol

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59483

Pneumococcal Vaccines Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Pneumococcal Vaccines Market– Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global pneumococcal vaccines market was valued at US$ 7,108.7 Mn in 2017 expanding at a CAGR of 5.1% from 2018 to 2026.

Browse the full report at https://www.credenceresearch.com/report/pneumococcal-vaccines-market

Market Insights

World Health Organization and U.S. Centers for Disease Control and Prevention (CDC) has recommended pneumococcal vaccination for all adults above age 65 and children below 2 years of age. Pneumococcal vaccine may or may not protect completely against pneumonia, however, it significantly reduces the risk of invasive pneumococcal diseases. Strong support by local government and private health organizations such as UNICEF and WHO have driven the demand for pneumococcal vaccines market. For instance, GAVI, a private and public alliance have contributed US$ 1.5 billion to the Advanced Market Commitment (AMC) for pneumococcal vaccines. GAVI has helped 60 countries to incorporate pneumococcal vaccines in their routine programs and immunized more than 143 million children globally in 2017. Moreover, Gavi has committed US$ 4 billion for pneumococcal vaccine by the 2021. Moreover, growing incidences of pneumococcal diseases worldwide is the driving factor for the growing demand for pneumococcal vaccines. Pneumonia is the leading reason for death in children accounting for more than 25% of deaths of children below age of 5. Growing burden of antibiotic resistance is one of the major challenges faced by the market.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59482

In terms of vaccine type, pneumococcal conjugate vaccines (PCV) held the largest share in the global pneumococcal market owing to more number of PCV products present in the market i.e. PCV10 and PCV 13. Moreover, on-going clinical trials of PCV15 and PCV20 by Merck & Co., Inc. and Pfizer, Inc. respectively will further drive the growth of PCV market during the forecast period. The pneumococcal polysaccharide vaccine (PPSV) market is projected to grow at steady rate during the forecast period. In terms of geography, North America held the largest share in the global pneumococcal vaccines market in 2017. Increasing government funding and awareness programs in the region is fueling the market. For instance, pneumococcal conjugate vaccine (PCV) has been introduced in the routine immunization program to curb the burden of pneumococcus diseases. Europe holds a significant share in the market due to efficient vaccination programs in countries such as Italy, Netherlands, United Kingdom and other countries. Asia Pacific is expected to grow at fastest rate during the forecast period owing to high incidences of pneumococcal diseases. High investment and partnerships by pharmaceutical companies will further drive the market. For instance, in 2017 Pfizer was granted patent protection for company’s PCV in India. The key players operating in the market include Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc.

Key Market Movements:

  • Growing burden of pneumococcal diseases worldwide and growing awareness regarding the same
  • Increasing government funding and introduction of effective vaccination programs to tackle the disease burden
  • High demand for pneumococcal vaccines in developing nations to drive the market
  • Strong support by WHO, UNICEF, GAVI and other private and public organization to fuel market growth

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59482

Immunocytokines Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Immunocytokines Market Growth, Future Prospects, and Competitive Analysis, 2018 – 2026” the immunocytokines market is growing at a CAGR of 7.6% during the forecast period from 2018 to 2026.

Browse the full report Immunocytokines Market Growth, Future Prospects, and Competitive Analysis, 2018 – 2026 at  https://www.credenceresearch.com/report/immunocytokines-market

Market Insights

Immunocytokines are the molecules produced when monoclonal antibodies (tumor-reactive) link with cytokines to trigger the immune cells in a living body. The increasing prevalence of cancer and hematological malignancies globally is a major factor driving the growth of the immunocytokines market. The global market is segmented on the basis of diseases indication and targeting sites. Presently, immunocytokines are mainly utilized for treating diseases such as cancer, tumors, and rheumatoid arthritis. These molecules are usually targeting at the fat muscle, liver, B and T lymphocytes, hypothalamus, and bone marrow endothelium for treatment. Increasing investment in R&D and government for conducting clinical trials to form new molecular entities is boosting the market growth globally. Presently, the pharmaceutical organizations in the U.S. and Europe are majorly focused on conducting clinical trials for specific categories such as Interferon, tumor necrosis factor (TNF), second generation Interleukin-2, first-generation Interleukin-2, Interleukin-10, Interleukin-15, and Interleukin-12.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59481

Advanced therapies for cancer and critical development in the production of monoclonal antibodies, antibody-drug conjugates, and immunocytokines provides better opportunities in developing nations. For e.g. cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy. Additionally, increasing demand for personalized medicines, large-scale production, changing lifestyles that habitually result in chronic diseases and the adoption of combination therapies will further spur revenue growth during the forecast period. However, unverifiable reimbursement scenario, lack of early diagnosis and treatment expensive medications, and non-availability of medications related to cancer in developing nations are the key market challenges in the global immunocytokines market.

Key Market Movements:

  • Globally, the immunocytokines market remains to exhibit a profitable growth with a CAGR of 7.6% for the period from 2018 to 2026
  • The development of the immunocytokines market mainly attributed to high pervasiveness of the cancer disorders along with higher output for better healthcare management
  • Increasing awareness and programs held by top cancer care institutes, beneficiary reimbursement coverage for treatment, the presence of top pharmaceutical manufacturers & sophisticated healthcare infrastructure in the U.S. and Canada is contributing maximum revenue share in North America immunocytokines market
  • Surging ageing population & a number of advanced healthcare settings, availability of cancer therapies and medications along increasing healthcare spending in Poland, Russia, Brazil, South Africa, India, China, and Japan contribute to overall growth of the market during the forecast period
  • Major players in this vertical are Alkermes Plc, AstraZeneca Plc, CytImmune, Cytune Pharma, Altor Biosciences Corporation, Apeiron Biologics AG, Paladin Labs, Teva Pharmaceutical Industries Ltd., Valor Biotherapeutics, Targa Therapeutics Corporation, Immunomedics, Inc., ImmunGene, Inc., MolMed S.p.A., Merck KGaA, Nektar Therapeutics, Pfizer, Inc., F. Hoffmann-La Roche, Ltd. and others

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59481

Proton Therapy Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Proton Therapy Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global proton therapy market was valued at US$ 767.3 Mn in 2017 and expected to reach US$ 2,834.8 Mn by 2026, expanding at a CAGR of 15.6% from 2018 to 2026.

Browse the full report Proton Therapy Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/proton-therapy-market

Market Insights

Since its first approval in 1988, proton therapy has been used for treating over 160,000 patients worldwide. It is expected that this number will more than double by 2030. As reported by the National Association for Proton Therapy (U.S.) the number of proton therapy centers more than doubled during the period from 2012 to 2016, with a 70% increase in the number of patients during the same period. Even with the rapid pace of establishments, until recently, this treatment has been inaccessible for most of the patients. Hospitals and oncology centers have struggled to bear the costs of the sophisticated particle accelerators, while some institutions have faced space constraint.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59480

However, a more sophisticated method of building proton therapy systems has been developed. Facilities are considering incorporation of proton therapy in the standard treatment options are finding potential benefit from the flexible and more affordable synchrotron systems. The conventional barriers to offering patients the access to proton therapy in terms of cost and space are being overcome by the modern modular construction and growing affordability in treatments.

Proton therapy though expensive is an attractive modality of modern radiation therapy. Protons have beneficial physical properties with minimizing the radiation dose to the adjacent healthy tissue while allowing for augmenting the delivered dose. Proton therapy is also critical in treating pediatric cancers, and rare situations such as recurrent chordomas, tumors in the midline central nervous system structures and craniospinal cancers. The enthusiasm associated with use of proton therapy for treatment of prostate cancer was based on the theory of superiority as against photon therapy in sparing healthy organs such as rectum, bladder, and femoral head. Historically, a majority of the investment in proton therapy centers was made with expecting that significant return on investment will come from prostate cancer treatment.

The development of proton therapy has led to expanding treatment capabilities therefore augmenting the number of potential patients. At present, over half of the total cancer patients are administered radiation therapy as a part of their treatment. As the market players continue to improve the administration and delivery of proton therapy, the treatment is set to evolve as a primary radiation treatment, especially in pediatric and inoperable cancers. However, high cost of investment, and uneven reimbursements are restraining the market growth.

The global proton therapy market is highly competitive in nature and is characterized by the presence of limited number of players. Continuous regulatory approvals, and collaborations are the key feature of this market resulting in stronger position of the existing market players. The players are signing collaborative agreements with major hospital chains and other players to incorporate novel technologies in the already established systems and development of advanced treatment solutions. Some of the prime market players in this industry are Ion Beam Applications SA, Varian Medical Systems, Hitachi Ltd., ProNova Solutions LLC, Sumitomo Heavy Industries Ltd., Mitsubishi Electric Corporation, ProTom International, Inc., Optivus Proton Therapy, Inc., Mevion Medical Systems and Advanced Oncotherapy.

Key Market Movements:

  • Growing prevalence of pediatric tumors to open expansion opportunities
  • Increasing evidence supporting the safety and advanced efficacy of proton therapy
  • High installation costs and large space requirement to restrain the market growth
  • Increasing demand for single room systems, especially in emerging economies where large investments for multiple room systems is a prominent challenge
  • Technological innovations ensuring improvement in safety profile of proton therapy as against X-ray therapy
  • Increasing demand for advanced radiation therapies in emerging economies of Asia Pacific

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59480

Coenzyme A Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Coenzyme A Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global coenzyme A market is expected to grow at a CAGR of 8.1% from 2018 to 2026.

Browse the full report Coenzyme A Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at  https://www.credenceresearch.com/report/coenzyme-a-market

Market Insights

Coenzyme A is a non-protein molecule biomolecule which catalyzes activation of several enzymes and drive important chemical reactions in human body. Naturally it is synthesized from vitamin B5 or pantothenic acid which is found in abundance in natural sources such as vegetables, meat, legumes and milk. Researchers have investigated that 4% of the human enzymes utilize coenzyme A as a cofactor or substrate, which has gained it immense popularity as a dietary supplement. Biotechnology research is being conducted on a large scale to tap its therapeutic efficacy.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59479

Lithium salts are the most stable derivative of coenzyme A currently used in biochemical reactions. The inherent features of trilithium salt is its ability to increase the stability of coenzyme A and render it inert in storage conditions. It is widely employed in biomedical research pertaining to inflammation and cell biology. Sodium salt derivative finds immense popularity in dietary supplements on account of its enhance solubility in aqueous solutions and rapid ion-exchange mechanism at cellular level.

Biotechnology research is gathering maximum revenue in the application segment for coenzyme A market. Coenzyme A is an important cofactor in several human metabolic biochemical mechanism. It has gained increasing popularity in pharmaceutical industry for its ability to prolong medicine half-life and in favoring the pharmacodynamics effect of drug at the receptor level. Dietary supplement will be the fastest growing market in application segment owing to the importance of coenzyme A in synthesizing fatty acids, proteins and ATP generation to promote cellular respiration and replication.

In the present scenario North America is the clear leader in regional segment for coenzyme A market. The key attributes responsible for the dominance of North America are flourishing biotechnology industry and increasing demand in pharmaceutical industry for coenzyme A salt derivatives in synthesizing important bioenzymes. In Europe the coenzyme A market growth is determined by rising public health awareness and domicile of major players such as SigmaAldrich, Merck KGaA and DSM. Asia Pacific serves as a lucrative market opportunity for key players on account of increasing number of patients suffering with metabolic disorders. Emerging local players exert competition to major players thereby posing a positive impetus to coenzyme A market growth in Asia Pacific.

The biomolecules manufacturing companies present in the coenzyme A market are Avanti Polar Lipids, Inc., BASF, Cayman Chemical, Creative Enzymes, DSM, Lee BioSolutions, Inc., Merck KGaA, PerkinElmer, Inc., SigmaAldrich and Thermo Fisher Scientific, Inc.

Key Market Movements:

  • Prospering biotechnology and dietary supplement industry
  • Rising importance of coenzyme A as an important cofactor in several intermediary biochemical mechanism
  • Production of coenzyme A salt derivatives are relatively easy in chemical labs and are widely employed by pharmaceutical industry for production of enzymes

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59479

Ultrasound Bladder Scanners Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Ultrasound Bladder Scanners Market Growth, Future Prospects, and Competitive Analysis, 2018 – 2026” the ultrasound bladder scanners market was valued at US$ 122.4 Mn in 2017 and expected to reach US$ 207.2 Mn by 2026 at a CAGR of 6.0% during the forecast period from 2018 to 2026.

Browse the full report at https://www.credenceresearch.com/report/ultrasound-bladder-scanner-market

Market Insights

The global ultrasound bladder scanners market shows dynamic growth during the forecast period from 2018 to 2026 attributed to an increase in the prevalence of urinary disorders, rising diagnostics procedures along with advanced portable devices. Novel technology assessment in real-time ultrasound scanning technology, the rise in manufacturing and growing demand for handheld devices is driving the market. These devices are also utilized for other urologic imaging applications by reducing the delays and expense of sonographers or specialized ultrasound equipment in hospitals or clinics. Improved focus on new product launches, collaborations, and partnerships among companies in North America expected to drive the growth globally. For instance, in August 2017, Clarius Mobile Health launched wireless C3 multipurpose ultrasound scanners with top mobile integrated applications. In addition, in November 2017, Verathon, Inc. launched its new portable 3-D ultrasound instrument, BladderScan Prime Plus embedded with advanced artificial intelligence. Moreover, in September 2017, EchoNous declared a new US$ 35 million investment from Kohlberg Kravis Roberts & Co. L.P. (KKR), a global investment firm.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59478

Other major factors driving the growth include rising hospitalizations for urinary tract infections, increasing ambulatory care, advancement in the digital industry, and utilization of advanced systems in the portable bladder ultrasound scanners segment. In addition, increasing partnerships with hospitals, growing demand for non-invasive and painless procedures will gain traction during the forecast period. However, the high cost of ultrasound bladder scanners, lack of healthcare infrastructure, less awareness, and affordability issues are restraining the market growth globally.

Key Market Movements:

  • Globally, the ultrasound bladder scanners market remains to exhibit a profitable growth with a CAGR of 6.0% for the period from 2018 to 2026
  • Higher technology assessment in the portable segment is gaining traction in the market
  • Europe, and the Asia Pacific to show promising opportunities owing to rising awareness, increase in adoption of handheld devices and improved healthcare infrastructure
  • Major players in this vertical are GE Healthcare Inc., Patricia Industries (LABORIE), Caresono, Roper Technologies, Inc., C. R. Bard, Inc., SRS Medical Systems, Inc., Mcube Technology Co., Ltd., Verathon Inc., Medline Industries, Inc., Vitacon, Mianyang Meike Electronic, dBMEDx, Inc., Meda Co., Ltd., ECHO-SON, Signostics, Inc. and others.

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59478

Nutrigenomics Market: Global Industry Size, Share, Growth, Strategies, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Nutrigenomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global nutrigenomics market was valued at US$ xx Mn in 2017, and is expected to reach US$ xx Mn by 2026, expanding at a CAGR of 16.3% from 2018 to 2026.

Browse the full report Nutrigenomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/nutrigenomics-market

Market Insights

Nutrigenomics is a branch of medical science where in the chronic disease are studied at genome level and nutritious diet is recommended for its treatment accordingly. There are no regulatory sanctions against any reagents and kits pertaining to nutrigenomics market. However ambiguity still persists regarding the ethical issues related to disclosure of genetic information of consumers through healthcare providers and clinical laboratories.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59477

Reagents and kits are reigning the product segment for nutrigenomics market. The key attributes responsible for its dominance are rampant growth in clinical laboratories worldwide and rising prevalence of chronic diseases such as obesity, diabetes, cardiovascular complication and cancer. Services segment is going to register impressive growth on account of technical innovations in IT healthcare services and apps. Mandatory generation of Electronic Health Record (EHR) of patients have given an impetus to the services segment.

As per the latest statistics provided by World Health Organization (WHO) in 2016, approximately 1.9 billion adults were reported overweight. The factors for this rampant growth in obesity are craving for junk food, sedentary lifestyle and leptin resistance. Chronic diseases will be responsible for three-fourths of the global mortality by 2020. Chronic diseases are being studied at genetic level to understand their etiology and how it can be reversed by nutritional science.

Currently saliva and buccal swabs are together dominating the test segment for nutrigenomics market. Consumers show a great inclination towards the oral sample collection method due to its inherent advantageous features such as quick, ease of collection, o pain and venipuncture associated with sample collection. Researchers are diligently working to address the bacterial contamination issue which destabilizes the DNA collected in oral samples. Other DNA collection methods such as hair and urine are being the cynosure of clinical research on account of factors such as less sample volume required, excellent storage and DNA quantification by techniques such as PCR.

North America is leading the regional segment for nutrigenomics market. Rising prevalence of chronic disease and rampant growth in the number of clinical laboratories drive the nutrigenomics market growth in North America. In Europe the government healthcare agencies have invested huge funds in academia research actively engaged in nutrigenomics studies. Increasing public health awareness also have a positive impact on the nutrigenomics market growth in North America. Asia Pacific is a potential market for key players associated with nutrigenomics to establish clinical laboratories and retail outlets. Untapped market in rural areas has a constructive effect on the nutrigenomics market growth in Asia Pacific.

Pharmaceutical companies providing reagents and kits to determine the nutrigenomics of human beings are Cura Integrative Medicine, Centogene, Genomix Nutrition, Inc., Metagenics, Inc., NutraGene, Nutrigenomix, Navigenics, XCODE Life Sciences, Pvt. Ltd., WellGen, Inc. and 23&Me, Inc.

Key Market Movements:

  • Rampant growth of clinical laboratories and increasing number of people suffering with chronic disease worldwide
  • Technical innovation in the IT healthcare services provided and availability of low cost reagent and test kits
  • Paradigm shift in the approach to treat lifestyle disorder analyzing disease etiology at genetic level and recommending nutrition respectively

Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/59477